Construction is officially underway on the planned $1.7 billion, state-of-the-art public health laboratory that will transform New York’s ability to detect, prevent, and respond to emerging public health threats. Construction… Read More
MISSISSAUGA, ON – Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 22, 2026, Health Canada has approved Gazyva® (obinutuzumab) for the treatment of adult patients with… Read More
Centre for Heart Lung Innovation Principal Investigator, Dr. Zachary Laksman, has co-founded MyTrials.ai, a platform that uses artificial intelligence (AI) to streamline clinical trial recruitment and support patients in making informed decisions… Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company), a leading global medical technology company, announced the global commercial release of BD® Research Cloud 7.0, furthering the company’s AI roadmap… Read More
Ontario is the first province to fund Tagrisso for patients with non-small cell lung cancer, and Calquence for patients with previously untreated mantle cell lymphoma MISSISSAUGA, ON – AstraZeneca Canada is… Read More
